ArticleAnnals of hematology2022

ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.

Naama Keren-Froim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.